Backs FY25 adjusted EBITDA (35M)-$5M.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PIII:
- P3 Health Partners price target lowered to $20 from $50 at Lake Street
- Upcoming Stock Splits This Week (April 14 to April 18) – Stay Invested
- P3 Health Partners Inc trading halted, news pending
- Hold Rating for P3 Health Partners Amid Capital Needs and Challenging Financial Outlook
- P3 Health Partners’ Earnings Call: Growth Amid Challenges